Veklury® (remdesivir) formulations inhibit initial membrane-coupled events of SARS-CoV-2 infection due to their sulfobutylether-β-cyclodextrin content

Kurtán KittiDr. Kovács TamásDr. Zákány FlorinaDr. Varga ZoltánDr. Panyi GyörgyDr. Nagy Péter2023-06-222023-06-222023-06https://hdl.handle.net/2437/356510Veklury® (remdesivir) formulations inhibit initial membrane-coupled events of SARS-CoV-2 infection due to their sulfobutylether-β-cyclodextrin content